American Century Companies’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,217
| Closed | -$293K | – | 2907 |
|
|
2024
Q4 | $293K | Sell |
5,217
-3,333
| -39% | -$207K | ﹤0.01% | 2690 |
|
|
2024
Q3 | $582K | Sell |
8,550
-4,520
| -35% | -$255K | ﹤0.01% | 2425 |
|
|
2024
Q2 | $552K | Buy |
13,070
+657
| +5% | +$36.1K | ﹤0.01% | 2406 |
|
|
2024
Q1 | $857K | Buy |
12,413
+11
| +0.1% | +$696 | ﹤0.01% | 2215 |
|
|
2023
Q4 | $918K | Buy |
12,402
+39
| +0.3% | +$2.56K | ﹤0.01% | 2110 |
|
|
2023
Q3 | $843K | Buy |
12,363
+488
| +4% | +$41.4K | ﹤0.01% | 2055 |
|
|
2023
Q2 | $1.12M | Sell |
11,875
-71
| -0.6% | -$5.54K | ﹤0.01% | 1890 |
|
|
2023
Q1 | $805K | Buy |
11,946
+3,961
| +50% | +$255K | ﹤0.01% | 1953 |
|
|
2022
Q4 | $395K | Buy |
+7,985
| New | +$326K | ﹤0.01% | 2125 |
|
|
2022
Q3 | – | Sell |
-5,775
| Closed | -$228K | – | 2449 |
|
|
2022
Q2 | $228K | Buy |
5,775
+15
| +0.3% | +$802 | ﹤0.01% | 2113 |
|
|
2022
Q1 | $403K | Buy |
5,760
+817
| +17% | +$59.7K | ﹤0.01% | 2030 |
|
|
2021
Q4 | $385K | Buy |
4,943
+1,307
| +36% | +$115K | ﹤0.01% | 2040 |
|
|
2021
Q3 | $347K | Buy |
3,636
+515
| +17% | +$54.4K | ﹤0.01% | 2031 |
|
|
2021
Q2 | $388K | Sell |
3,121
-761
| -20% | -$90.8K | ﹤0.01% | 1957 |
|
|
2021
Q1 | $512K | Buy |
3,882
+817
| +27% | +$112K | ﹤0.01% | 1714 |
|
|
2020
Q4 | $406K | Buy |
3,065
+112
| +4% | +$13.5K | ﹤0.01% | 1633 |
|
|
2020
Q3 | $301K | Sell |
2,953
-934,026
| -100% | -$80.7M | ﹤0.01% | 1553 |
|
|
2020
Q2 | $81.5M | Buy |
936,979
+210,151
| +29% | +$16.8M | 0.08% | 263 |
|
|
2020
Q1 | $42.2M | Sell |
726,828
-74,870
| -9% | -$6.08M | 0.05% | 330 |
|
|
2019
Q4 | $74.1M | Buy |
801,698
+157,775
| +25% | +$13.9M | 0.07% | 288 |
|
|
2019
Q3 | $58.2M | Buy |
643,923
+200,529
| +45% | +$22.8M | 0.06% | 318 |
|
|
2019
Q2 | $52.3M | Buy |
443,394
+157
| +0% | +$15.8K | 0.05% | 356 |
|
|
2019
Q1 | $38.4M | Buy |
+443,237
| New | +$37.7M | 0.04% | 402 |
|
|
2018
Q2 | – | Sell |
-131,134
| Closed | -$5.29M | – | 1308 |
|
|
2018
Q1 | $5.29M | Buy |
131,134
+48,026
| +58% | +$2.34M | 0.01% | 822 |
|
|
2017
Q4 | $4.37M | Buy |
83,108
+23,264
| +39% | +$1.24M | ﹤0.01% | 873 |
|
|
2017
Q3 | $2.82M | Buy |
59,844
+527
| +0.9% | +$21.2K | ﹤0.01% | 976 |
|
|
2017
Q2 | $2.1M | Sell |
59,317
-18,357
| -24% | -$567K | ﹤0.01% | 1028 |
|
|
2017
Q1 | $1.83M | Buy |
77,674
+5,721
| +8% | +$113K | ﹤0.01% | 1058 |
|
|
2016
Q4 | $961K | Hold |
71,953
| – | – | ﹤0.01% | 1133 |
|
|
2016
Q3 | $1.34M | Buy |
71,953
+8,422
| +13% | +$148K | ﹤0.01% | 1123 |
|
|
2016
Q2 | $778K | Buy |
+63,531
| New | +$479K | ﹤0.01% | 1186 |
|
|
2015
Q4 | – | Sell |
-112,151
| Closed | -$2.02M | – | 1319 |
|
|
2015
Q3 | $2.02M | Buy |
112,151
+62,826
| +127% | +$1.44M | ﹤0.01% | 1015 |
|
|
2015
Q2 | $1.47M | Sell |
49,325
-24,650
| -33% | -$619K | ﹤0.01% | 1084 |
|
|
2015
Q1 | $1.63M | Sell |
73,975
-430
| -0.6% | -$10.9K | ﹤0.01% | 1076 |
|
|
2014
Q4 | $2.04M | Buy |
74,405
+14,935
| +25% | +$363K | ﹤0.01% | 1081 |
|
|
2014
Q3 | $1.15M | Sell |
59,470
-5,406
| -8% | -$99.1K | ﹤0.01% | 1151 |
|
|
2014
Q2 | $1.1M | Buy |
64,876
+8,510
| +15% | +$117K | ﹤0.01% | 1197 |
|
|
2014
Q1 | $799K | Sell |
56,366
-4,130
| -7% | -$55.8K | ﹤0.01% | 1267 |
|
|
2013
Q4 | $707K | Sell |
60,496
-190
| -0.3% | -$2.18K | ﹤0.01% | 1296 |
|
|
2013
Q3 | $717K | Buy |
60,686
+3,740
| +7% | +$48K | ﹤0.01% | 1296 |
|
|
2013
Q2 | $792K | Buy |
+56,946
| New | +$619K | ﹤0.01% | 1247 |
|
Other funds holding EXAS
American Century Companies's EXAS Position: Q1 2025 in Review
American Century Companies sold out of Exact Sciences (EXAS) in Q1 2025, closing a stake of 5,217 shares — an estimated $293K sold.
American Century Companies first reported a position in EXAS in Q2 2013 and held it in 41 quarters. The position peaked at $81.5M in Q2 2020. 558 funds tracked by Wall St. Rank hold EXAS as of Q1 2025.
- American Century Companies reported no remaining Exact Sciences position as of Q1 2025 after selling out during the quarter.
- American Century Companies sold 5,217 Exact Sciences shares in Q1 2025, an estimated $293K.
- American Century Companies first reported a position in Exact Sciences in Q2 2013 and held it in 41 quarters.
- American Century Companies's Exact Sciences position peaked at $81.5M in Q2 2020.
- 558 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2025.
Based on American Century Companies's 13F filing for Q1 2025, filed 13 May 2025.